Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

XBiotech Inc

XBIT ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$2.33

▲ +0.00%

Market Cap $70.12M · Vol 7.09K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$70.12M

Micro Cap

Div Yield

N/A

Dividend with no set frequency

EPS Growth

N/A

YoY

RSI (14)

58.14

Momentum

Beta

0.86

vs Market

52W High

$3.61

35.46% below

52W Low

$2.10

10.95% above

Volume

7.09K

Avg 11.62K

P/B

0.52

Price-to-book

ROE

N/A

Return on equity

Free Float

75.67%

Public shares

Shariah Compliance8 STANDARDS

✗ XBiotech Inc (XBIT) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does XBIT pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+2.64%

+1.75%

-6.80%

-4.90%

YTD

-2.51%

-28.09%

-51.96%

-85.40%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-45,540,000.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-25.95% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	0.52
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	30.49M

Technical Indicators

50-Day SMA	$2.31
200-Day SMA	$2.40
RSI (14)	58.14
Beta	0.86
52-Week High	$3.61
52-Week Low	$2.10

Volume Today	7.09K
Avg Daily Volume (30D)	11.62K
Relative Volume	0.61x
Volatility (10D)	39.93
Volatility (30D)	30.32
Free Float	75.67%

Analyst Consensus

N/A

Current Price $2.33

Mean Target N/A

52W Low$2.10 52W High$3.61

Current

Target

$2.10 $3.61

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG0081S8D48

ISINCA98400H1029

CountryUnited States of America

Sub-IndustryBio Therapeutic Drugs

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd -2.85% ARGX.BR argenx SE -3.21% ARGX argenx SE -0.66% INSM Insmed Inc -2.05% 2269.HK WuXi Biologics (Cayman) Inc -1.27%

Company Profile

XBiotech Inc. is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies for treating a variety of diseases, such as inflammatory conditions like rheumatology, infectious disease, cardiovascular disease and cancer. The Company's True Human monoclonal antibodies are derived from human donors that mount a natural human immune response. The Company is focused on therapies that block a potent substance, known as interleukin-1 alpha (IL-1a), that mediates a number of pathophysiological processes including tissue breakdown (i.e. synovium, cartilage, bone), paraneoplastic angiogenesis and tumor stroma remodeling, formation of blood clots, malaise, muscle wasting and general inflammation. It has various candidate products, including Natrunix. It has a clinical-stage therapeutic for methicillin resistant Staphylococcus aureus (MRSA), and several pre-clinical-stage therapeutics, including an oral delivery antibody therapeutic for colon infection by C. difficile.